arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Electromed, Inc.

ELMD
$42.40 ▲ +0.47 (+1.12%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
16 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
78
Health
Good
Bullish
auto_awesome

Analytical Summary

Electromed, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $358.5M
Dividend Yield
Revenue Growth 17.0%
Op. Margin 15.1%
ROIC 16.4%
FCF / Share $1.32
Trailing P/E 47.6x
Price / Book 8.2x
FCF Yield 3.1%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

16-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$64.00M
↑ +17.0%
Net Income Profit after all expenses
$7.54M
↑ +46.3%
Operating Margin Operating profit as % of sales
15.1%
↑ +25.5% 67th
FCF / Share Free cash flow per share
$1.32
↑ +28.4%
Long-Term Debt Long-term obligations
$1.15M
— +0.1%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
71
Returns
84
Cash Quality
79

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 64 quarters